AnaptysBio, Inc. Names Director of Cell Biology; Joins from Regeneron Pharmaceuticals, Inc., Adds Extensive Therapeutic Antibody Discovery Credentials

November 17, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

SAN DIEGO--(BUSINESS WIRE)--AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced the appointment of Dr. Sean Stevens as director of cell biology.

Twitter
LinkedIn
Facebook
Email
Print

People

AnaptysBio, Inc. Regeneron Pharmaceuticals, Inc.